121
Ultrasound in Muscle Biopsy
Condition(s): Myopathy; Myositis; Muscular Dystrophy Last Updated: February 12, 2013Recruiting
145 Clinical Trials for: “Muscular Dystrophy”, Page 7 of 8
Hide Studies Not Seeking New Volunteers
122
Study of Albuterol and Oxandrolone in Patients With Facioscapulohumeral Dystrophy (FSHD)
Condition(s): Muscular Dystrophies Last Updated: January 31, 2006Completed
123
Molecular and Genetic Studies of Congenital Myopathies
Condition(s): Central Core Disease; Centronuclear Myopathy; Congenital Fiber Type Disproportion; Multiminicore Disease; Myotubular Myopathy; Nemaline Myopathy; Rigid Spine Muscular Dystrophy; Undefined Congenital Myopathy Last Updated: April 8, 2013Recruiting
124
Endomysial Fibrosis, Muscular Inflammatory Response and Calcium Homeostasis Dysfunction in Duchenne Muscular Dystrophy
Condition(s): Duchenne Muscular Distrophy (DMD) Last Updated: March 29, 2013Recruiting
125
Dysphagia in Oculopharyngeal Muscular Dystrophy (OPMD)- Evaluation, Endoscopic Examination of Swallowing, Treatment and Long Term Follow up
Condition(s): Dysphagia Last Updated: July 21, 2010Recruiting
126
Skeletal Muscle Biomarkers in People With Fragile Sarcolemmal Muscular Dystrophy
Condition(s): Genetic Disorder Last Updated: May 9, 2013Recruiting
127
Protein Supplementation and Exercise in FSHD Patients - a Blinded RCT Study
Condition(s): Facioscapulohumeral Muscle Dystrophy Last Updated: June 12, 2012Enrolling by invitation
128
Clinical Outcome Study for Dysferlinopathy
Condition(s): Dysferlinopathy; LGMD2B; Miyoshi Myopathy Last Updated: May 2, 2013Recruiting
129
The Contribution of Heels for Walking Quality Among Children With Muscular Dystrophy
Condition(s): Step Time and Length; Symmetry; Step Time and Length Variability; Heart Rate; Gait Velocity Last Updated: April 23, 2013Not yet recruiting
130
Deflazacort in Dysferlinopathies
Condition(s): LGMD2B; Miyoshi Myopathy; Dysferlinopathy Last Updated: January 27, 2009Completed
131
Clinical Efficacy Trial of Mexiletine for Myotonic Dystrophy Type 1
Condition(s): Myotonic Dystrophy Last Updated: January 31, 2013Recruiting
132
Postural Spirometry Changes in Ambulatory Myotonic Dystrophy Patients
Condition(s): Myotonic Dystrophy Last Updated: November 15, 2010Completed
133
Efficacy and Safety of DHEA for Myotonic Dystrophy
Condition(s): Myotonic Dystrophy Last Updated: April 5, 2010Completed
134
Efficacy and Tolerance of Early Launching of Nocturnal Non Invasive
Condition(s): Myopathy; Muscular Weakness; Respiratory Insufficiency Last Updated: December 12, 2011Recruiting
135
Effects of SomatoKine (Iplex)Recombinant Human Insulin-like Growth Factor-1/Recombinant Human Insulin-like Growth Factor-binding Protein-3 (rhIGF-I/rhIGFBP-3) in Myotonic Dystrophy Type 1 (DM1)
Condition(s): Myotonic Dystrophy Last Updated: June 20, 2012Completed
136
DM1 Heart Registry - DM1 Respiratory Registry
Condition(s): Myotonic Dystrophy Last Updated: February 17, 2012Completed
137
Genetic and Family Studies of Inherited Muscle Diseases
Condition(s): Dermatomyositis; Glycogen Storage Disease Type II; Glycogen Storage Disease Type VII; Myositis; Polymyositis Last Updated: March 4, 2008Completed
138
Cardiovascular Consequences of NIV Withdrawal in Patients With Myotonic Dystrophy
Condition(s): Myotonia Last Updated: August 10, 2012Recruiting
139
Efficacy and Tolerance of AVAPS Mode in Myotonic Dystrophy
Condition(s): Myopathy Last Updated: February 26, 2013Recruiting
140
Safety and Efficacy Study of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/rhIGFBP-3) In Myotonic Dystrophy Type 1
Condition(s): Myotonic Dystrophy Type 1 Last Updated: July 21, 2008Active, not recruiting
